Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 11033 - 11040 of 11617 results
DOJ's Strategies - FCPA and Health Care Fraud
March 31, 2012| Blog| Viewpoint
HHS Issues Report to Congress on the Self-Referral Disclosure Protocol
March 28, 2012| Blog| Viewpoint
HIPAA Omnibus Rule Expected Within 90 Days - Pending Review at OMB
March 27, 2012| Blog| Viewpoint
Pinterest Announces Changes To Its Terms Of Service
March 26, 2012| Blog| Viewpoint
What Every Developer Should Know About Affordable Housing
March 26, 2012| News
SEC Issues Investor Bulletin Regarding Municipal Bonds
March 21, 2012| Blog| Viewpoint
Job Applicants Asked for Facebook Passwords
March 21, 2012| Blog| Viewpoint
OIG Approves Wholly Owned Subsidiary GPO Arrangement
March 21, 2012| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.